Asthma Spacers Market Size To Be Worth USD 2.38 Billion by 2027 Growing at a CAGR of 3.4% | Emergen Research

The rising asthma prevalence and increase in environmental pollution are driving the demand for the Asthma Spacers market.

Vancouver, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The Global Asthma Spacers Market is forecast to be worth USD 2.38 Billion by 2027, according to the current analysis by Emergen Research. The asthma spacers market is expected to expand exponentially over the forecast timeline due to the rising asthma cases. Asthma accounts for 13.8 million missed school days per year and is the most prevalent chronic condition in childhood. For adults, it also accounts for 14.2 million missed working days in North America. The rising environmental pollution is forecast to further propel the market growth, as the adverse weather conditions can worsen asthma. Moreover, the development of cross valve technology is also anticipated to augment market growth.

The lack of knowledge among consumers about this product is expected to restrain the market growth over the forecast timeline.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@

Key Highlights From The Report

  • In June 2020, Roche Pharma India extends an alliance for oncology drugs with Cipla Limited. This partnership will ensure that the company's focus on delivering Roche innovations in India continues steadily in this pipeline and will continue to work with relevant Indian health system stakeholders to ensure improved patient outcomes. This alliance reflects the extreme commitment of Cipla to meet the unmet needs of cancer patients through an expanded range of offerings.
  • Due to the advantages of metered-dose inhaler treatment for patients, the Optichamber segment is expected to see substantial growth over the predicted timeframe.
  • The largest segment in the forecast timeline is expected to be the retail pharmacy segment. As with the use of home care, people tend to buy medications from local pharmacies rather than visit hospitals.
  • During the forecast timeframe, the hospital pharmacy is expected to experience significant growth. Since doctors from hospitals give the prescription, some people tend to buy drugs from the hospital pharmacy due to better availability and accessibility.
  • Europe is expected to be the second-largest market in the forecast period due to the presence of key market players in this region.
  • The market in the Asia Pacific region is estimated to witness the fastest growth during the forecast period. Increasing investments in healthcare and growing improvements in healthcare facilities are expected to accelerate regional market growth.
  • Key participants include Lupin Limited, Trudell Medical Group Ltd., GlaxoSmithKline plc, Cipla Limited, Merck & Co., Inc, Clement Clarke International Ltd, PARI GmbH, AstraZeneca plc/AB, Fisons plc, and Allergan plc among others.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@

Emergen Research has segmented the Global Asthma Spacers Market based on type, distribution channel, end-use, and region:

  • Type Outlook (Revenue: USD Billion; 2017-2027)
    • Inspirease
    • Optichamber
    • Aerochamber
    • Volumatic
  • Distribution Channel Outlook (Revenue: USD Billion; 2017-2027)
    • E-commerce
    • Retail Pharmacy
    • Hospital Pharmacy
  • End-Use Outlook (Revenue: USD Billion; 2017-2027)
    • Homecare
    • Clinics & Hospitals
    • Others

To identify the key trends in the industry and read full summary click on the link:

  • Regional Outlook (Revenue: USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@

Contact Data